Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Oct 10;37(7):e370702.
doi: 10.1590/acb370702. eCollection 2022.

Tranexamic acid effects in postoperative bleeding outcomes in laparoscopic sleeve gastrectomy: a controlled study

Affiliations
Randomized Controlled Trial

Tranexamic acid effects in postoperative bleeding outcomes in laparoscopic sleeve gastrectomy: a controlled study

Roger Moura de Brito et al. Acta Cir Bras. .

Abstract

Purpose: To demonstrate through a controlled study whether the use of tranexamic acid in bariatric surgeries is effective for bleeding control.

Methods: Prospective, comparative, and double-blind study performed with patients from 18 to 65 years old submitted to bariatric surgery. The selected patients received venous tranexamic acid (TXA) during the induction of anesthesia or not (CG). The anesthesia and thromboprophylaxis protocols were similar among the groups. For statistical analysis, the χ2 and analysis of variance tests were performed at a significance level of p < 0.05, using the statistical program SPSS 21.0®.

Results: Sixty-one patients were included in the study, 31 in the control group and 30 in the TXA group (GTXA). In the intraoperative period, the bleeding volume was greater in the CG than in the GTXA. In the postoperative period, the tranexamic acid group had a higher value hematocrit, absence of surgical reoperations due to bleeding complications, and shorter hospitalization time than the control group.

Conclusions: The use of tranexamic acid was effective in reducing bleeding rates and of hospital stay length, in addition to demonstrating the clinical safety of its use, for not having been associated with any thromboembolic events.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Nothing to declare.

Figures

Figure 1
Figure 1. Study consort flowchart.

Similar articles

Cited by

References

    1. Fletcher R, Deal R, Kubasiak J, Torquati A, Omotosho P. Predictors of increased length of hospital stay following laparoscopic sleeve gastrectomy from the national surgical quality improvement program. J Gastrointest Surg. 2018;22(2):274–278. doi: 10.1007/s11605-017-3642-4. - DOI - PubMed
    1. Temperley L, Sullivan A, Ruban A. Bariatric surgery and the endoscopist. Frontline Gastroenterol. 2021;12(7):683–687. doi: 10.1136/flgastro-2020-101681. - DOI - PMC - PubMed
    1. Hedjoudje A, Dayyeh BKA, Cheskin LJ, Adam A, Neto MG, Badurdeen D, Kumbhari V. Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020;18(5):1043–1053.:e4. doi: 10.1016/j.cgh.2019.08.022. - DOI - PubMed
    1. Silecchia G, Iossa A. Complications of staple line and anastomoses following laparoscopic bariatric surgery. Ann Gastroenterol. 2018;31(1):1–9. doi: 10.20524/aog.2017.0201. - DOI - PMC - PubMed
    1. Van Rijswijk, Evren I, Geubbels N, Hutten BA, Acherman YI, van der Peet DL, Bruin SC. Outcome expectation and risk tolerance in patients seeking bariatric surgery. Surg Obes Relat Dis. 2021;17(1):139–146. doi: 10.1016/j.soard.2020.08.020. - DOI - PubMed

Publication types

MeSH terms